Biocon Rating ‘Neutral’; firm in position to revive earnings growth

[ad_1]


Earnings CAGR of 36% estimated over FY21-23e; ‘Neutral’ retained with TP of Rs 360 as price factors in upside over medium term

[ad_2]

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Polynion

Binance Prediction

Metamask

papamiaspizza.com

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99

RAJANAGA99